Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MyPAO Planning Report

K-Number: K200589 · 2021-02-19

Decision Date2021-02-19
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

MyPAO Planning Report is a medical device manufactured by Medacta International S.A.. It received FDA 510(k) clearance on 2021-02-19 under approval number K200589. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MyPAO Planning Report?

MyPAO Planning Report is a medical device that received FDA 510(k) clearance on 2021-02-19. It is manufactured by Medacta International S.A.. The 510(k) number is K200589.

When was MyPAO Planning Report approved by the FDA?

MyPAO Planning Report received FDA 510(k) clearance on 2021-02-19, under approval number K200589.

What company makes MyPAO Planning Report?

MyPAO Planning Report is manufactured by Medacta International S.A..

What is the FDA product code for MyPAO Planning Report?

The FDA product code for MyPAO Planning Report is LLZ.

Other Devices by Medacta International S.A.

View all 146 devices →

Related Devices (Code: LLZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.